Received Oct 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | LA |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | RA |
Body aches; Fever of up to 101 lasting more than 24 hours; nausea; fatigue; This is a spontaneous report received from a Consumer or other non HCP. A 30-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 21Oct2025 at 11:00 as dose 1, single (Batch/Lot number: unknown) at the age of 30 years, in left arm for covid-19 immunisation; influenza vaccine (FLU [INFLUENZA VACCINE]), on 21Oct2025 as dose number unknown, single, in right arm for immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "endometriosis" (unspecified if ongoing); "dermatographism" (unspecified if ongoing). Concomitant medication(s) included: NORETHINDRONE [NORETHISTERONE]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; FAMOTIDINE. Past drug history included: Betadine, reaction(s): "allergy". The following information was reported: PAIN (non-serious) with onset 21Oct2025 at 17:00, outcome "recovering", described as "Body aches"; PYREXIA (non-serious) with onset 21Oct2025 at 17:00, outcome "recovering", described as "Fever of up to 101 lasting more than 24 hours"; FATIGUE (non-serious) with onset 21Oct2025 at 17:00, outcome "recovering"; NAUSEA (non-serious) with onset 21Oct2025 at 17:00, outcome "recovering". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain, pyrexia, nausea, fatigue. Additional information: Fever of up to 101 lasting more than 24 hours. Body aches, nausea, fatigue. Treatment received for the adverse event with Tylenol. The patient was not received any other vaccines within 4 weeks prior to the vaccine(s) for which you are reporting. The vaccine was administered at workplace clinic. The patient was taking any other medications within 2 weeks of the event starting. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Asthma; Dermatographism; Endometriosis
NORETHINDRONE [NORETHISTERONE]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; FAMOTIDINE
Test Date: 20251021; Test Name: Body temperature; Result Unstructured Data: Test Result:101